English  |  正體中文  |  简体中文  |  2822924  
???header.visitor??? :  30089995    ???header.onlineuser??? :  990
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"shih j y"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 326-350 of 1137  (46 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-05-02T03:29:26Z Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life Hsieh C.-C.;Ho C.-C.;Lin Z.-Z.;Chong-Jen Yu;Jow G.-M.;Huang F.-Y.;Shih J.-Y.;Hsiao F.-H.; Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; CHONG-JEN YU; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; Hsiao F.-H.
臺大學術典藏 2021-05-02T03:29:25Z The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation Wu S.-G.;Chong-Jen Yu;Yang J.C.-H.;Shih J.-Y.; Wu S.-G.; CHONG-JEN YU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2021-05-02T03:29:24Z Effect of β-Blocker in Treatment-Na?ve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs Chang C.-H.;Lee C.-H.;Ko J.-C.;Chang L.-Y.;Lee M.-C.;Zhang J.-F.;Wang J.-Y.;Shih J.-Y.;Chong-Jen Yu; Chang C.-H.; Lee C.-H.; Ko J.-C.; Chang L.-Y.; Lee M.-C.; Zhang J.-F.; Wang J.-Y.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏 2021-05-02T03:29:21Z Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; CHONG-JEN YU
臺大學術典藏 2021-05-02T03:29:21Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU
朝陽科技大學 2021-05 Removal of soluble microbial products and dyes using heavy metal wastes decorated on eggshell Chen, S.-J.; Shih, J.-Y.; Koyande, A.K.; Liu, B.-L.; Chang, Y.-K.; 劉炳嵐; Chai, W.S.; Lin, T.-Y.
臺大學術典藏 2021-04-30T07:26:49Z Assessing tumor angiogenesis using dynamic contrast-enhanced integrated magnetic resonance-positron emission tomography in patients with non-small-cell lung cancer Huang Y.-S.; JENNY LING-YU CHEN; Chen H.-M.; Yeh L.-H.; Shih J.-Y.; Yen R.-F.; Chang Y.-C.
臺大學術典藏 2021-04-29T05:09:26Z Primary pulmonary plasmacytoma with lobar consolidation: An unusual presentation KUAN-YU CHEN; Wu H.-D.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:25Z Lung cancer in pregnancy: Report of two cases KUAN-YU CHEN; Wang H.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:19Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.; Gow C.-H.; Yu C.-J.; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; KUAN-YU CHEN; Su W.-P.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:17Z Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapy Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chang Y.-C.; Hu F.-C.; Tsai M.-C.; KUAN-YU CHEN; Lin Z.-Z.; Huang C.-J.; Shun C.-T.; Huang C.-L.; Bean J.; Cheng A.-L.; Pao W.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:15Z Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer Wu J.-Y.; Shih J.-Y.; Yang C.-H.; KUAN-YU CHEN; Ho C.-C.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:15Z EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment Huang C.-L.; Yang C.-H.; Yeh K.-H.; Hu F.-C.; KUAN-YU CHEN; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:14Z Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer Lee J.-H.; Yu C.-J.; KUAN-YU CHEN; Shih J.-Y.; Lin Y.-L.; Yang C.-H.
臺大學術典藏 2021-04-29T05:09:14Z Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors KUAN-YU CHEN; Chen J.-H.; Shih J.-Y.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:12Z The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma Kuo Y.-W.; Jerng J.-S.; Shih J.-Y.; KUAN-YU CHEN; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:12Z Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations Wu J.-Y.; Shih J.-Y.; KUAN-YU CHEN; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:11Z Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: The association with treatment efficacy of pemetrexed Chen C.-Y.; Chang Y.-L.; Shih J.-Y.; Lin J.-W.; KUAN-YU CHEN; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:10Z Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors Hsu C.-L.; KUAN-YU CHEN; Shih J.-Y.; Ho C.-C.; Yang C.-H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:07Z Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; KUAN-YU CHEN; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2021-04-29T05:09:07Z Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer Liao W.-Y.; Chen J.-H.; Wu M.; Shih J.-Y.; KUAN-YU CHEN; Ho C.-C.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2021-04-29T05:09:06Z Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer Lee J.-H.; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; KUAN-YU CHEN; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H.
臺大學術典藏 2021-04-29T05:09:04Z Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis Hsu C.-L.; Chen J.-H.; KUAN-YU CHEN; Shih J.-Y.; Yang J.C.H.; Yu C.-J.; Yang P.-C.
臺大學術典藏 2021-04-29T05:09:03Z Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Chang G.-C.
臺大學術典藏 2021-04-29T05:09:03Z Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer Chen C.-Y.; Lin J.-W.; Huang J.-W.; KUAN-YU CHEN; Shih J.-Y.; Yu C.-J.; Yang P.-C.

Showing items 326-350 of 1137  (46 Page(s) Totally)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
View [10|25|50] records per page